SCHEMBL9526669

SCHEMBL9526669

CCOC(=O)C(CCc1ccccc1)NC1CSCC(C(C)C)N(C(C)C(=O)O)C1=O

nearest known ligand 0.56

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ACE P12821 6/20 0.50
ABCB11 O95342 1/20 0.50
AGTR2 P50052 1/20 0.50
PDE3A Q14432 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
KDM4E B2RXH2 1/20 0.49
CYP3A4 P08684 1/20 0.49
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9530543 0.93 ACE (0.49) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526210 0.91 ACE (0.52) ACE
SCHEMBL9526762 0.88 ACE (0.49) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526740 0.86 ACE (0.56) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9525288 0.86 ACE (0.56) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9525274 0.86 ACE (0.56) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9525281 0.86 ACE (0.56) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526312 0.85 ACE (0.50) ACE
SCHEMBL10833127 0.83 ACE (0.50) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL10832435 0.83 ACE (0.50) ACEABCB11AGTR2PDE3ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0365045-B1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1993-12-01 EP disclosed
EP-0365045-A1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1990-04-25 EP disclosed
US-4699905-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1987-10-13 US disclosed
EP-0161801-A2 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1985-11-21 EP disclosed